Signal Transduction and Targeted Therapy (Dec 2023)
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
Abstract
No abstracts available.
Signal Transduction and Targeted Therapy (Dec 2023)